Psychopharmacology: Recent Advances and Future ProspectsSusan D. Iversen Proceedings of the Tenth Anniversary meeting of the British Association for Psychopharmacology, providing a general review of the subject. |
Contents
How effective are antidepressants? | 3 |
Central nervous system patterns of neurochemical abnormality | 13 |
Platelet transport and receptor sites in depressive illness | 21 |
Copyright | |
20 other sections not shown
Common terms and phrases
abnormalities action activity addition administration agonists alcohol Alzheimer's amphetamine animals antidepressant anxiety appear Arch associated behaviour benzodiazepine binding brain caffeine cause cent central changes cholinergic chronic clinical clomipramine cognitive compounds concentration controls correlation cortex cortical decreased dementia dependence depressed patients depression depressive illness disease disorders dopamine doses drugs effects et al evidence example findings function half-life human impairment important improvement increased induced inhibition inhibitors involved Iversen known lesions less levels loss major mechanism memory mianserin neurones nicotine normal observed occur Parkinson's disease patients performance Perry Pharmac pharmacological phase placebo platelet possible potential present Press processes produced properties Psychiat rats recent receptors reduced relatively release reported response reuptake schizophrenia selective severe showed shown significant similar specific stimulant studies subjects suggested symptoms Table therapeutic therapy tion treatment tricyclic withdrawal